Health workers' perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso

• Main Authors: Sylvain F. Nkwenkeu (Author), Mohamed F. Jalloh (Author), Jenny A. Walldorf (Author), Robert L. Zoma (Author), Felix Tarbangdo (Author), Soukeynatou Fall (Author), Sansan Hien (Author), Roland Combassere (Author), Cesaire Ky (Author), Ludovic Kambou (Author), Alpha Oumar Diallo (Author), Akshaya Krishnaswamy (Author), Flavien H. Aké (Author), Cynthia Hatcher (Author), Jaymin C. Patel (Author), Isaïe Medah (Author), Ryan T. Novak (Author), Terri B. Hyde (Author), Heidi M. Soeters (Author), Imran Mirza (Author)
• Format: Book
• Published: BMC, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Meningococcal serogroup A conjugate vaccine (MACV) was introduced in 2017 into the routine childhood immunization schedule (at 15-18 months of age) in Burkina Faso to help reduce meningococcal meningitis burden. MACV was scheduled to be co-administered with the second dose of mea...